Loading...
Core Scientific, Inc.
CORZW•NASDAQ
TechnologySoftware - Infrastructure
$6.44
$0.23(3.70%)
Core Scientific, Inc. (CORZW) Financial Performance & Statements
Review Core Scientific, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
1.65%
↑ 1.65%
Operating Income Growth
-314.22%
↓ 314.22%
Net Income Growth
-433.50%
↓ 433.50%
Operating Cash Flow Growth
-34.12%
↓ 34.12%
Operating Margin
-28.27%
↓ 28.27%
Gross Margin
12.57%
↑ 12.57%
Net Profit Margin
-229.98%
↓ 229.98%
ROE
134.28%
↑ 134.28%
ROIC
-8.12%
↓ 8.12%
Core Scientific, Inc. (CORZW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Core Scientific, Inc. stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $94.92M | $95.35M | $141.10M | $179.29M |
Cost of Revenue | $90.16M | $95.51M | $102.28M | $101.64M |
Gross Profit | $4.76M | -$156000.00 | $38.82M | $77.65M |
Gross Profit Ratio | $0.05 | -$0.002 | $0.28 | $0.43 |
R&D Expenses | $5.02M | $2.84M | $2.17M | $1.80M |
SG&A Expenses | $38.58M | $37.51M | $29.21M | $15.13M |
Operating Expenses | $44.55M | $40.35M | $31.38M | $16.92M |
Total Costs & Expenses | $134.71M | $135.86M | $133.67M | $118.57M |
Interest Income | $0.00 | $0.00 | $14.78M | $0.00 |
Interest Expense | $1.14M | $7.07M | $0.00 | $14.09M |
Depreciation & Amortization | $29.16M | $28.69M | $31.46M | $29.77M |
EBITDA | -$234.88M | -$419.36M | -$758.52M | $254.75M |
EBITDA Ratio | -$2.47 | -$4.40 | $0.28 | $0.50 |
Operating Income | -$39.78M | -$41.22M | $7.43M | $60.72M |
Operating Income Ratio | -$0.42 | -$0.43 | $0.05 | $0.34 |
Other Income/Expenses (Net) | -$225.38M | -$413.91M | -$812.19M | $155.67M |
Income Before Tax | -$265.17M | -$455.13M | -$804.75M | $210.90M |
Income Before Tax Ratio | -$2.79 | -$4.77 | -$5.70 | $1.18 |
Income Tax Expense | $375000.00 | $134000.00 | $144000.00 | $206000.00 |
Net Income | -$265.54M | -$455.26M | -$804.90M | $210.69M |
Net Income Ratio | -$2.80 | -$4.77 | -$5.70 | $1.18 |
EPS | -$0.87 | -$1.56 | -$4.51 | $0.91 |
Diluted EPS | -$0.87 | -$1.56 | -$4.51 | $0.75 |
Weighted Avg Shares Outstanding | $306.15M | $292.49M | $178.50M | $230.95M |
Weighted Avg Shares Outstanding (Diluted) | $306.15M | $292.49M | $178.50M | $282.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan